Venetoclax as monotherapy or in combination: Patterns of use and predictors of outcomes in an international multicenter study of CLL patients Meeting Abstract
| Authors: | Mato, A. R.; Roeker, L. E.; Eyre, T. A.; Nabhan, C.; Lamanna, N.; Hill, B. T.; Brander, D. M.; Barr, P.; Lansigan, F.; Cheson, B.; Singavi, A. K.; Yazdy, M.; Shah, N. N.; Allan, J. N.; Bhavsar, E. B.; Rhodes, J.; Kennard, K.; Schuster, S. J.; Williams, A. M.; Skarbnik, A. P.; Goy, A.; Coombs, C. C.; Tuncer, H. H.; Ujjani, C. S.; Jacobs, R.; Winter, A. M.; Pagel, J. M.; Bailey, N.; Schuh, A.; Shadman, M.; Sitlinger, A.; Weissbrot, H.; Muralikrishnan, S.; Kirkwood, A. A.; Fox, C. P. |
| Abstract Title: | Venetoclax as monotherapy or in combination: Patterns of use and predictors of outcomes in an international multicenter study of CLL patients |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454842800292 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-114840 |
| Notes: | Meeting Abstract: 3142 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
